<DOC>
	<DOCNO>NCT00994435</DOCNO>
	<brief_summary>Insulin secretion insulin sensitivity related inverse , hyperbolic function , call disposition index , show critical importance ß-cell dysfunction development T2DM . A consequence hyperbolic relationship increase insulin resistance compensate up-regulation insulin secretion , happen obesity . However , defective insulin secretion relation insulin sensitivity take place ( i.e . reduce disposition index ) impair glucose tolerance type 2 diabetes develop . The investigator recently demonstrate bilio-pancreatic diversion determines prompt reversibility T2DM normalize peripheral insulin sensitivity enhance ß-cell sensitivity glucose ; change occur within day surgery , largely change body weight occur . This operation may affect entero-insular axis function , divert nutrient away proximal gastro-intestinal tract deliver incompletely digest nutrient ileum , thus abnormally stimulate secretion intestinal incretins . It show male Wistar rat undergo three different type small intestinal surgery , namely ileal transposition ( either 10 20 cm low ileum transpose mid-duodenum ) 85 % jejuno-ileal bypass , show sustain post-operative reduction food intake significant change body weight gain . All experimental group large increase basal meal-stimulated enteroglucagon , area curve plasma level gastrin , gastric inhibitory polypeptide ( GIP ) , insulin blood glucose significantly reduce . GIP produce mainly duodenum jejunum show dog .The aim present study investigate intestinal site production incretins response intraluminal nutrient stimulation order establish relationship insulin resistance , insulin hypersecretion different small intestinal segment insulin resistance condition , obesity T2DM . To purpose mixed test meal infuse duodenum , proximal jejunum ileum glucose uptake insulin secretion study , relation glucagon incretin response . Studies carry 20 obese subject sex , 10 type 2 diabetes 10 normal glucose tolerance .</brief_summary>
	<brief_title>The Incretin Secretion Gut System Related Physiological Stimulus</brief_title>
	<detailed_description>For intestinal perfusion , tube assembly ( out diameter 7 mm ) mark length scale use . It consist six tube bond together tetrahydrofuran ( Sigma Chemical Corp , St Louis , Missouri , USA ) . Three tube connect balloon use occlude intestinal lumen proximal site infusion . Three tube radio-opaque allow fluoroscopic location assembly ; distal end immediately distal proximal occlude balloon ( perfusion site ) position 60 cm ( duodenum ) , 90 cm ( proximal jejunum ) 120 cm ( distal jejunum ) nose . After 12 hour fast , subject swallow tube assembly . The position assembly confirm fluoroscopy . With tube right position , occlude balloon inflate 60 ml air perfusion distal intestinal segment start . . The perfusion perform use continuous pump accord follow scheme : 100 ml/h 30 minute 110 ml/h 60 minute 123 ml/h 60 minute 133 ml/h 30 minute test period , follow 120 minute absorption period . Each subject study 3 different session 7-10 day distance randomly select order study effect insulin sensitivity secretion test meal delivery different intestinal segment ( i.e . duodenum , proximal jejunum , distal jejunum ) . Blood sample glucose , free fatty acid ( FFA ) insulin , C-peptide , glucagon , GLP-1 , GIP , drawn -30 minute 0 , 15 , 30 , 40 , 60 , 80 , 100 , 120 , 150 , 180 , 240 , 300 360 minute test period . The lipid-glucose-protein test meal mixture ScandiShake ( 85 g powder mixed 240-mL milk result 69.5 g carbohydrate , 30.4 g fat , 11.7 g protein ) .</detailed_description>
	<mesh_term>Incretins</mesh_term>
	<criteria>Males female Women fertile age engage avoid pregnancy study protocol . Before start experimental session pregnancy test perform pregnant woman exclude investigation . All woman study follicular phase menstrual cycle 30 60 year old . HbA1c 6.5 8.5 % ( patient T2DM ) BMI 3040 Kg /m2 Past active medical history major endocrinological , renal , cardiac , respiratory , liver gastrointestinal disease . All Diabetic patient must never treat oral hypoglycemic agent insulin .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>obesity</keyword>
</DOC>